infliximab IV - tocilizumab IV en SC - natalizumab IV - denosumab SC
TED · 628378-2026Contract noticeCloses in 31 days · 2026-10-13
Value
Estimated—
Awarded—
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
infliximab IV - tocilizumab IV en SC - natalizumab IV - denosumab SC
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-08-04 | 2025/1746 - EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 90% |
| 2026-06-09 | 2025/1746 -EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 90% |
| 2026-07-21 | 2023/0491 - TRASTUZUMAB [600 MG/ 5 ML SOL INJ SC FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 90% |
| 2026-06-09 | 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 90% |
| 2026-05-19 | Suministro de Infliximab (DOE), Ustekinumab (DOE) y Bevacizumab (DOE) | OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES | 90% |
| 2026-07-28 | 2025/1746 - EMICIZUMAB [150 MG/ML 0,7 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 89% |